Ascites Phase 2 Clinical Trial

If you or one of your loved ones suffers from ascites due to liver cirrhosis – Welcome!
Please find more information about our Phase 2 clinical study of a new drug therapy to potentially treat this condition at A Study for Evaluation of BIV201 to Reduce Ascites.

If you are interested in joining this clinical trial, and live within reach of one of our clinical trial sites, please contact the Clinical Study Coordinator at the nearest location. (scroll down for contact information)
BIV201 Clinical Trial Sites – Ascites due to Liver Cirrhosis

What is ascites?

Ascites (ay-SITE-eez) is when too much fluid builds up in your abdomen (belly). This condition often happens in people who have cirrhosis (scarring) of the liver.
A sheet of tissue called the peritoneum covers the abdominal organs, including the stomach, bowels, liver and kidneys. The peritoneum has two layers. Ascites happens when fluid builds up between the two layers.

What are risk factors for ascites?

Having a condition that causes cirrhosis puts you at greater risk for developing ascites. These conditions include:
• Non-alcohol associated fatty liver disease (“NAFLD”), which can progress to non-alcoholic steatohepatitis (“NASH”)
• Hepatitis B and C
• Alcohol use disorder
• Autoimmune hepatitis
• Genetic liver diseases like hemochromatosis, Wilson disease and alpha-1-antitrypsin deficiency*

Mayo Clinic Gastroenterology
and Hepatology

200 First St. SW
Rochester, MN 55905
Study Coordinator:
Amy Olofson

Mayo Clinic Gastroenterology
and Hepatology

4500 San Pablo Road
Jacksonville, FL 32224
Study Coordinators:
Temetria Miller

Katelyn Register


MUSC Health University Medical Center

114 Doughty St.
Suite 268
Charleston, SC 29425
Study Coordinator:
Shelia Parnell

Penn Gastroenterology
Perelman Center for Advanced Medicine

3400 Civic Center Boulevard
Philadelphia, PA 19104
Study Coordinator:
Calvin Trisolini

Ronald Reagan UCLA Medical Center

Ronald Reagan UCLA Medical Center
757 Westwood Plaza
Los Angeles, CA 90095
Study Coordinator:
Connie Landon

University of Miami

1400 NW 14th Street
Room 969
Miami, FL 33136
Study Coordinator:
Michael Mijares

Schiff Center for Liver Disease

1500 NW 12th Avenue
Suite # 1101-JMT-E
Miami, FL 33136
Study Coordinator:
Lourdes Olson

Edgar Medina Restrepo

Vanderbilt Digestive Disease Center

1301 Medical Center Drive,
Suites 1660 and 3701
Nashville, TN 37232
Study Coordinator:
Kathryn Campbell

Hunter Holmes McGuire
VA Medical Center

Hunter Holmes McGuire
VA Medical Center
1201 Broad Rock Blvd
Richmond, VA 23249
Study Coordinator:
Edith Gavis
Forward Looking Statements
This website contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, and assumptions that could cause BioVie’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements.
Sign-up to follow our progress
* indicates required
9120 Double Diamond Parkway
Suite 1400
Reno, NV 89521
(775) 888-3162

© Copyright 2012 - 2021 | BioVie Inc. | ALL RIGHTS RESERVED |